Literature DB >> 10497101

Human cytomegalovirus US3 gene expression is regulated by a complex network of positive and negative regulators.

B J Biegalke1.   

Abstract

One immediate early gene of human cytomegalovirus, the US3 gene, causes retention of major histocompatibility locus class I heavy chain proteins in the endoplasmic reticulum and is postulated to have a role in viral pathogenicity. Expression of the US3 gene is regulated by a number of cis-acting elements. In addition, numerous viral proteins are involved in regulating US3 gene expression. US3 transcription was activated modestly by a virion protein, ppUL82. The immediate early proteins encoded by UL122-123 (IE1 and IE2) further activate US3 expression, with the activation enhanced by expression of pTRS1. Other proteins, the immediate early protein encoded by UL37ex1/UL38 and the early protein, pUL84, inhibited IE1 and IE2 activation of US3 expression. US3 transcription is regulated both positively and negatively by a complex network of viral proteins, the interaction of which contributes to precise regulation of US3 gene expression. The ability of pUL37ex1/UL38 to repress expression of the immediate early US3 gene while activating early gene expression suggests that pUL37ex1/UL38 may function to switch viral gene expression from immediate early to early genes. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10497101     DOI: 10.1006/viro.1999.9881

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  10 in total

1.  Trafficking of UL37 proteins into mitochondrion-associated membranes during permissive human cytomegalovirus infection.

Authors:  Petros Bozidis; Chad D Williamson; Daniel S Wong; Anamaris M Colberg-Poley
Journal:  J Virol       Date:  2010-05-26       Impact factor: 5.103

2.  Two gamma interferon-activated site-like elements in the human cytomegalovirus major immediate-early promoter/enhancer are important for viral replication.

Authors:  James Netterwald; Shaojun Yang; Weijia Wang; Salena Ghanny; Michael Cody; Patricia Soteropoulos; Bin Tian; Walter Dunn; Fenyong Liu; Hua Zhu
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

3.  The human cytomegalovirus protein UL37 exon 1 associates with internal lipid rafts.

Authors:  Chad D Williamson; Aiping Zhang; Anamaris M Colberg-Poley
Journal:  J Virol       Date:  2010-12-22       Impact factor: 5.103

4.  Identification of a novel transcriptional repressor encoded by human cytomegalovirus.

Authors:  L A LaPierre; B J Biegalke
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

5.  A short isoform of human cytomegalovirus US3 functions as a dominant negative inhibitor of the full-length form.

Authors:  Jinwook Shin; Boyoun Park; Sungwook Lee; Youngkyun Kim; Bonita J Biegalke; Seongman Kang; Kwangseog Ahn
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

6.  The human cytomegalovirus UL35 gene encodes two proteins with different functions.

Authors:  Yingguang Liu; Bonita J Biegalke
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

7.  Intracellular sorting signals for sequential trafficking of human cytomegalovirus UL37 proteins to the endoplasmic reticulum and mitochondria.

Authors:  Chad D Williamson; Anamaris M Colberg-Poley
Journal:  J Virol       Date:  2010-04-21       Impact factor: 5.103

8.  Tale of a tegument transactivator: the past, present and future of human CMV pp71.

Authors:  Rhiannon R Penkert; Robert F Kalejta
Journal:  Future Virol       Date:  2012-09-01       Impact factor: 1.831

Review 9.  Access of viral proteins to mitochondria via mitochondria-associated membranes.

Authors:  Chad D Williamson; Anamaris M Colberg-Poley
Journal:  Rev Med Virol       Date:  2009-05       Impact factor: 6.989

Review 10.  Functional annotation of human cytomegalovirus gene products: an update.

Authors:  Ellen Van Damme; Marnix Van Loock
Journal:  Front Microbiol       Date:  2014-05-19       Impact factor: 5.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.